moomoo ID:NaN
Log Out
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IPHA Innate Pharma > Company Executives
IPHA Innate Pharma
NamePositionSalaryService DateEducationAgeGenderUpdated
Dr. Mondher Mahjoubi, M.D.Chairman of the Executive Board and Chief Executive Officer1.49M----63male04/04/2022
Dr. Joyson Joseph Karakunnel, M.D.Executive Vice President and Chief Medical officer------51male04/04/2022
Mr. Eric Vivier, PhDSenior Vice President and Chief Scientific Officer------57male04/04/2022
Mr. Frederic LombardChief Financial Officer------47male04/04/2022
Mr. Yannis Morel, PhDMember of the Executive Board and Executive Vice President, Product Portfolio Strategy and Business Development637.85K----48male04/04/2022
Ms. Odile BelzunceVice President, Compliance, IT and Portfolio Management------41female04/04/2022
Ms. Odile LaurentVice President, Human Resources------59female04/04/2022
Ms. Nicola BeltraminelliVice President, Development--------female04/04/2022
Mr. Herve Brailly, PhDChairman of the Supervisory Board------60male04/04/2022
Ms. Irina Staatz-Granzer, PhDVice Chairman of the Supervisory Board40.10K----61female04/04/2022
Dr. Patrick J. Langlois, PhDMember of the Supervisory Board65.40K----76male04/04/2022
Professor Jean-Yves Blay, PhDMember of the Supervisory Board23.00K----59male04/04/2022
Mr. Gilles BrissonMember of the Supervisory Board34.90K----69male04/04/2022
Dr. Veronique Chabernaud, M.D.Member of the Supervisory Board59.00K----60female04/04/2022
Ms. Pascale BoisselMember of the Supervisory Board38.80K----55female04/04/2022
Mr. Olivier MartinezMember of the Supervisory Board------51male04/04/2022
Company Overview More
Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Herv? Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fourni?, and Fran鏾is Romagn? on September 23, 1999 and is headquartered in Marseille, France.
CEO: Dr. Mondher Mahjoubi, M.D.
Market: NASDAQ
Listing Date: 10/17/2019
Hot List
SymbolLatest price%Chg